Raymond Woosley, president, CEO and board chairman of the Critical Path Institute, will retire from his position as president on Jan. 31, 2012. The institute's board is currently recruiting for someone to fill this post.
Woosley has said he plans to remain involved in C-Path. After his retirement as president, he will continue serving on the board of directors and leading C-Path’s Arizona Center for Education and Research on Therapeutics.
Woosley launched C-Path in 2005 to provide independent guidance to the US Food and Drug Administration and industry on drug development issues, so that new treatments can enter the market quickly. Under Woosley's leadership, C-Path currently employs more than 50 scientists. The institute has expanded beyond its headquarters in Arizona to operating offices in Rockville, Md., to be closer to the FDA and policy issues in Washington, DC.